Jeffrey D Esko

This inventor holds 10 USPTO granted patents and 7 published patent applications. Top assignees: University of California, Tega Therapeutics, Inc., The State University of New York. Active years: 1997-2026.

USPTO Granted Patents = 10 (Patent Applications = 7)

% Patents Active = 70.0

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 86(Granted Patents)

Location History:

Birmingham, AL (US) (1997)
San Diego, CA (US) (2010 - 2023)

Company Filing History:

7 out of 15,977

University of California

patents

2 out of 2

Tega Therapeutics, Inc.

patents

1 out of 2,043

The State University of New York

patents

4. 1 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12636353 - Application of microbial glycosidase as an anti-viral therapeutic, prognostic, and diagnostic (2026-05-26),

2. 12636307 - In vitro heparin and heparan sulfate compositions and methods of making and using (2026-05-26),

3. 12600778 - RAGE ANTIBODIES, FRAGMENTS AND USES THEREOF (2026-04-14),

4. 11549000 - Cellular glycosaminoglycan compositions and methods of making and using (2023-01-10),

5. 10543283 - Intranasal administration of guanidinylated aminoglycosides (2020-01-28),

6. 10449230 - Polymyxin derived cell penetrating scaffolds (2019-10-22),

7. 9889182 - Assisted enzyme replacement therapy (2018-02-13),

8. 9757468 - Intranasal administration of guanidinylated aminoglycosides (2017-09-12),

9. 7772192 - Compositions and methods for treatment of disease with acetylated disaccharides (2010-08-10),

10. 5639734 - Disaccharide inflammation inhibitors and uses thereof (1997-06-17),

Title: The Innovations of Jeffrey D. Esko

Introduction

Jeffrey D. Esko is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic compositions and methods. With a total of 10 patents, his work has had a substantial impact on medical research and treatment options.

Latest Patents

Esko's latest patents include innovative compositions and methods related to heparin and heparan sulfate. One notable patent focuses on in vitro heparin and heparan sulfate compositions, detailing methods of making and using cellular-derived products. Another significant patent addresses the application of microbial glycosidase as an anti-viral therapeutic, prognostic, and diagnostic tool. This patent outlines methods for diagnosing, preventing, or treating viral infections, including COVID-19, by administering effective amounts of glycosidase or sulfatase to degrade glycans like heparan sulfate.

Career Highlights

Throughout his career, Jeffrey D. Esko has worked with esteemed institutions such as the University of California and Tega Therapeutics, Inc. His research has been pivotal in advancing our understanding of viral infections and potential therapeutic interventions.

Collaborations

Esko has collaborated with notable colleagues, including Yitzhak Tor and Wenyong Tong. Their combined expertise has contributed to the success of various research projects and innovations in the field.

Conclusion

Jeffrey D. Esko's contributions to biochemistry and his innovative patents highlight his role as a leading inventor in the medical research community. His work continues to influence the development of new therapeutic methods and compositions.